State Ledger
Company profile

Silo Pharma, Inc. CIK 1514183

Ticker
SILO (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Sarasota, FL 34236
Fiscal year end
2025 (FY)
Market Data
Close
$1.47
Change
+$0.03
Change %
2.08%
Volume
824

SILO · trading date Oct 12, 2026 · previous close $1.44 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$72.1K
Net income
-$4.23M
Total assets
$7.61M
Total liabilities
$1.30M
Stockholders' equity
$6.31M
Cash & equivalents
$4.75M
Operating income
-$4.28M
Operating cash flow
-$4.66M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-27. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-5,937.0%
Net margin
-5,863.5%
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
17.1%
Equity / assets
82.9%
CapEx / revenue
—
Operating cash flow / net income
1.10×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $72.1K -$4.23M $7.61M $1.30M $6.31M
2024 $72.1K -$4.39M $7.41M $2.38M $5.03M
2023 $72.1K -$3.70M $7.75M $1.57M $6.18M
2022 $72.1K -$3.91M $11.64M $1.30M $10.34M
2021 — $3.90M $10.49M $1.43M $9.06M
Company Details
SIC code
2834
State of incorporation
NV
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-08-19
Financials filed via
Form 10-K
filed 2026-03-27

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Sarasota, FL 34236
677 N. WASHINGTON BLVD
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:25 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Florida — Public Companies